News Alkem Laboratories Limited

Stocks

ALKEM

INE540L01014

Pharmaceuticals

Market Closed - NSE India S.E. 07:05:07 2026-10-28 EDT			5-day change	1st Jan Change
5,070.00 ^INR	-0.16%		+1.32%	-7.93%

10-12	Alkem Laboratories Limited Announces Management Appointments, Effective October 12, 2026	CI
09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer	CI

All News

Mentions Relevance

10-12	Alkem Laboratories Limited Announces Management Appointments, Effective October 12, 2026	CI
09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer	CI
09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Key Managerial Personnel and Senior Management Personnel, Effective September 30, 2026	CI
09-16	Alkem Laboratories Limited Launches Neuceno for the Treatment of Partial-Onset Seizures in Adult Patients	CI
09-15	Alkem Laboratories Limited Announces Appointment of Shubhadeep Sinha to Senior Management Position, Effective September 15, 2026	CI
09-08	Alkem Laboratories Limited Launches Renocia Exo, India?s First Patented Ginsenoside Exosome-Based Hair Growth Serum	CI
08-14	Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026
08-14	Alkem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-03	Alkem Laboratories Limited Announces Appointment of Rajpal Singh Rana to Senior Management Position, Effective August 03, 2026	CI
07-23	Alkem Laboratories Limited Announces Resignation of Resignation of Jitendra Singh Huda as Senior Management Personnel, Effective from July 23, 2026	CI
06-02	Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350	CI
06-02	Alkem Laboratories Shows Strong Moves But Weak Follow-Through
05-29	Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638	MT
05-29	Jefferies Adjusts Alkem Laboratories' Price Target to INR6,500 From INR6,550, Keeps at Buy	MT
05-28	Alkem Laboratories Limited, Q4 2026 Earnings Call, May 28, 2026
05-28	Alkem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-28	Alkem Laboratories Limited Recommends Final Dividend for Financial Year Ended 31 March, 2026, Payable on and from 01 September, 2026	CI
05-18	Alkem Laboratories Limited Appoints Chanakya Misra to Senior Management Position, Effective May 18, 2026	CI
05-08	Alkem Labs says US FDA conducts unannounced inspection at Alkem CRO facility	RE
05-08	Alkem Laboratories Limited Receives No Form 483 After US FDA Inspection At CRO Facility Located At Taloja	CI
05-05	Alkem Labs says Order-In-Appeal drops tax demand of 696.6 million rupees	RE
05-04	Alkem Laboratories Gets 7 Observations from US FDA After Daman Plant Inspection	MT
04-24	Alkem Labs gets tax demand of 3.3 billion rupees	RE
04-24	Alkem Laboratories Limited Announces Resignation of Vikas Gupta as Key Managerial Personnel, Effective June 30, 2026	CI
04-24	Alkem Laboratories Limited Announces Resignation of Chief Executive Officer Vikas Gupta, Effective June 30, 2026	CI